INS and type 1 diabetes mellitus: We systematically collected and analysed all available evidence from RCTs directly comparing currently available insulin treatments, including HCL, AHCL, and FCL therapy, on the key outcomes of time in glycaemic ranges in people with type 1 diabetes.